KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Apr 27, 2021 $0.0889 $0.0900 $0.0625 $0.0800 69 611
Apr 26, 2021 $0.0760 $0.0900 $0.0581 $0.0900 120 934
Apr 23, 2021 $0.0626 $0.100 $0.0626 $0.0790 56 282
Apr 22, 2021 $0.0699 $0.0719 $0.0626 $0.0719 19 806
Apr 21, 2021 $0.0680 $0.0700 $0.0605 $0.0690 31 746
Apr 20, 2021 $0.0533 $0.0699 $0.0510 $0.0680 43 547
Apr 19, 2021 $0.0700 $0.0700 $0.0555 $0.0625 11 923
Apr 16, 2021 $0.0500 $0.0700 $0.0500 $0.0700 21 714
Apr 15, 2021 $0.0682 $0.0715 $0.0600 $0.0715 19 115
Apr 14, 2021 $0.0575 $0.0715 $0.0575 $0.0715 29 369
Apr 13, 2021 $0.0686 $0.0719 $0.0600 $0.0700 115 143
Apr 12, 2021 $0.0700 $0.0719 $0.0700 $0.0710 27 671
Apr 09, 2021 $0.0800 $0.0800 $0.0630 $0.0719 177 384
Apr 08, 2021 $0.0698 $0.0881 $0.0640 $0.0640 79 577
Apr 07, 2021 $0.0795 $0.0795 $0.0630 $0.0697 30 057
Apr 06, 2021 $0.0555 $0.0830 $0.0555 $0.0760 70 895
Apr 05, 2021 $0.0800 $0.0800 $0.0700 $0.0790 9 583
Apr 01, 2021 $0.0625 $0.0790 $0.0625 $0.0790 9 868
Mar 31, 2021 $0.0798 $0.0840 $0.0621 $0.0780 16 935
Mar 30, 2021 $0.0848 $0.0848 $0.0600 $0.0699 82 243
Mar 29, 2021 $0.0615 $0.0850 $0.0612 $0.0729 125 103
Mar 26, 2021 $0.0620 $0.0875 $0.0611 $0.0865 105 457
Mar 25, 2021 $0.0889 $0.0889 $0.0610 $0.0860 55 148
Mar 24, 2021 $0.0900 $0.0900 $0.0700 $0.0889 94 221
Mar 23, 2021 $0.0700 $0.0990 $0.0610 $0.0855 183 753
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT